Pre-Ocular Treatment Counseling: This pre-treatment counseling should include detailed information about NAION, diabetic retinopathy progression, and other vision-related adverse events associated with GLP-1 receptor agonists
2014 Feb;13(1):8-12
Table of Contents Understanding GLP-1 Therapy in Type 1 Diabetes Potential Benefits and Clinical Outcomes Risks, Safety Concerns, and Limitations Patient Selection and Practical Considerations Understanding GLP-1 Therapy in Type 1 Diabetes GLP-1 receptor agonists are well established in type 2 diabetes, yet their role in type 1 diabetes remains off-label
The market's initial enthusiasm for HIMS's GLP-1 play, which saw the stock bid up multiple times in 2025, has now given way to a more cautious, risk-averse stance
Her experience as a creative storyteller includes a range of lifestyle and technology topics across Washington D.C
Read more about the risks of Ozempic